218 related articles for article (PubMed ID: 23258640)
1. Efficacy of vitamin E in the conservative treatment of Peyronie's disease: legend or reality? A controlled study of 70 cases.
Paulis G; Brancato T; D'Ascenzo R; De Giorgio G; Nupieri P; Orsolini G; Alvaro R
Andrology; 2013 Jan; 1(1):120-8. PubMed ID: 23258640
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of antioxidants (propolis, blueberry, vitamin E) associated with verapamil in the medical management of Peyronie's disease: a study of 151 cases.
Paulis G; D'Ascenzo R; Nupieri P; De Giorgio G; Orsolini G; Brancato T; Alvaro R
Int J Androl; 2012 Aug; 35(4):521-7. PubMed ID: 21950543
[TBL] [Abstract][Full Text] [Related]
3. Long-term multimodal therapy (verapamil associated with propolis, blueberry, vitamin E and local diclofenac) on patients with Peyronie's disease (chronic inflammation of the tunica albuginea). Results of a controlled study.
Paulis G; Cavallini G; Giorgio GD; Quattrocchi S; Brancato T; Alvaro R
Inflamm Allergy Drug Targets; 2013 Dec; 12(6):403-9. PubMed ID: 24304332
[TBL] [Abstract][Full Text] [Related]
4. Peironimev-Plus® in the treatment of chronic inflammation of tunica albuginea (Peyronie's disease). results of a controlled study.
Paulis G; Cavallini G; Brancato T; Alvaro R
Inflamm Allergy Drug Targets; 2013 Feb; 12(1):61-7. PubMed ID: 23004005
[TBL] [Abstract][Full Text] [Related]
5. Use of intralesional verapamil to dissolve Peyronie's disease plaque: a long-term single-blind study.
Rehman J; Benet A; Melman A
Urology; 1998 Apr; 51(4):620-6. PubMed ID: 9586617
[TBL] [Abstract][Full Text] [Related]
6. Comparison of transdermal electromotive administration of verapamil and dexamethasone versus intra-lesional injection for Peyronie's disease.
Mehrsai AR; Namdari F; Salavati A; Dehghani S; Allameh F; Pourmand G
Andrology; 2013 Jan; 1(1):129-32. PubMed ID: 23258641
[TBL] [Abstract][Full Text] [Related]
7. Intralesional injection of the calcium channel blocker Verapamil in Peyronie's disease: A critical review.
Asali M; Asali M
Arch Ital Urol Androl; 2020 Oct; 92(3):. PubMed ID: 33016057
[TBL] [Abstract][Full Text] [Related]
8. Verapamil versus saline in electromotive drug administration for Peyronie's disease: a double-blind, placebo controlled trial.
Greenfield JM; Shah SJ; Levine LA
J Urol; 2007 Mar; 177(3):972-5. PubMed ID: 17296390
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of intralesional injection of hyaluronic acid compared with verapamil in Peyronie's disease: preliminary results from a prospective, double-blinded, randomized study.
Favilla V; Russo GI; Zucchi A; Siracusa G; Privitera S; Cimino S; Madonia M; Cai T; Cavallini G; Liguori G; D'Achille G; Silvani M; Franco G; Verze P; Palmieri A; Torrisi B; Mirone V; Morgia G
Andrology; 2017 Jul; 5(4):771-775. PubMed ID: 28718527
[TBL] [Abstract][Full Text] [Related]
10. Combination of intralesional verapamil and oral antioxidants for Peyronie's disease: a prospective, randomised controlled study.
Favilla V; Russo GI; Privitera S; Castelli T; Madonia M; La Vignera S; Condorelli R; Calogero AE; Farina FP; Cimino S; Morgia G
Andrologia; 2014 Oct; 46(8):936-42. PubMed ID: 24124921
[TBL] [Abstract][Full Text] [Related]
11. Transdermal iontophoresis with verapamil and dexamethasone in the acute phase of peyronie's disease. Our experience.
Garrido Abad P; Coloma A; Herranz LM; Jiménez M; Suárez C; Prieto MD; Formoso T; Fernández Arjona M
Arch Esp Urol; 2012 Oct; 65(8):745-51. PubMed ID: 23117682
[TBL] [Abstract][Full Text] [Related]
12. Sildenafil 25 mg ODT + Collagenase Clostridium hystoliticum vs Collagenase Clostridium hystoliticum Alone for the Management of Peyronie's Disease: A Matched-Pair Comparison Analysis.
Cocci A; Cito G; Urzì D; Minervini A; Di Maida F; Sessa F; Mari A; Campi R; Falcone M; Capece M; Morelli G; Cacciamani G; Rizzo M; Polito C; Giammusso B; Morgia G; Verze P; Salonia A; Cai T; Mirone V; Mondaini N; Russo GI
J Sex Med; 2018 Oct; 15(10):1472-1477. PubMed ID: 30245025
[TBL] [Abstract][Full Text] [Related]
13. Intralesional verapamil for the treatment of Peyronie's disease: a review.
Levine LA; Estrada CR
Int J Impot Res; 2002 Oct; 14(5):324-8. PubMed ID: 12454681
[TBL] [Abstract][Full Text] [Related]
14. Intralesional hyaluronic acid: an innovative treatment for Peyronie's disease.
Gennaro R; Barletta D; Paulis G
Int Urol Nephrol; 2015 Oct; 47(10):1595-602. PubMed ID: 26257044
[TBL] [Abstract][Full Text] [Related]
15. Comparative Effectiveness of Intralesional Therapy for Peyronie's Disease in Controlled Clinical Studies: A Systematic Review and Network Meta-Analysis.
Russo GI; Cacciamani G; Cocci A; Kessler TM; Morgia G; Serefoglu EC; Albersen M; Verze P;
J Sex Med; 2019 Feb; 16(2):289-299. PubMed ID: 30692028
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of Collagenase Clostridium histolyticum (Xiapex
Cocci A; Di Maida F; Russo GI; Capogrosso P; Francesco L; Rizzo M; Di Mauro M; Salonia A; Cito G; Falcone M; Romano A; Polloni G; Martinez-Salamanca JI; Fernández-Pascual E; Minervini A; Mondaini N
Clin Drug Investig; 2020 Jun; 40(6):583-588. PubMed ID: 32342279
[TBL] [Abstract][Full Text] [Related]
17. A prospective, randomized, single - blind study comparing intraplaque injection of thiocolchicine and verapamil in Peyronie's Disease: a pilot study.
Toscano L; Rezende MV; Mello LF; Paulillo D; Glina S
Int Braz J Urol; 2016; 42(5):1005-1009. PubMed ID: 24893912
[TBL] [Abstract][Full Text] [Related]
18. Effect of intralesional interferon-alpha 2b combined with oral vitamin E for treatment of early stage Peyronie's disease: a randomized and prospective study.
Inal T; Tokatli Z; Akand M; Ozdiler E; Yaman O
Urology; 2006 May; 67(5):1038-42. PubMed ID: 16581113
[TBL] [Abstract][Full Text] [Related]
19. Effect of intralesional verapamil for treatment of Peyronie's disease: a randomized single-blind, placebo-controlled study.
Shirazi M; Haghpanah AR; Badiee M; Afrasiabi MA; Haghpanah S
Int Urol Nephrol; 2009; 41(3):467-71. PubMed ID: 19199072
[TBL] [Abstract][Full Text] [Related]
20. Safety and tolerability of local treatment with iloprost, a prostacyclin analogue, in patients with Peyronie's disease: a phase I study.
Pavone C; Napoli G; Caruana G; Alonge V; Usala M; Abbadessa D
BJU Int; 2012 Jul; 110(1):117-21. PubMed ID: 22176734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
